SCHEMBL260257

SCHEMBL260257

CCC(Cl)(Cl)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5518153 0.76
SCHEMBL1982189 0.76
SCHEMBL30668861 0.73
SCHEMBL8722255 0.73
SCHEMBL27708623 0.72
Methane SCHEMBL10705120 0.72 MEN1 (0.31)
SCHEMBL9618159 0.71
Methylene Chloride SCHEMBL565915 0.69 ALDH1A1 (0.33)
Methylene Chloride SCHEMBL7421886 0.69 ALDH1A1 (0.33)
Trichlorethanol SCHEMBL10345797 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114316102-B Alkoxy magnesium carrier, polyethylene catalyst and preparation method thereof 北京吉海川科技发展有限公司 2023-12-22 CN claimed
CN-114316102-A Alkoxy magnesium carrier, polyethylene catalyst and preparation method thereof 北京吉海川科技发展有限公司 2022-04-12 CN claimed
CN-109134716-B Vanadium catalyst and method for preparing olefin polymer 北京引发科技有限公司 2020-11-10 CN claimed
CN-109517188-A A kind of biology base composite flame-retardant agent and its application 广东省测试分析研究所(中国广州分析测试中心) 2019-03-26 CN claimed
CN-107119334-B A kind of apocynum fibre degumming method of comprehensive utilization 梁国柱 2019-02-19 CN claimed
CN-109180507-A Ketoprofen haptens, artificial antigen and antibody and its preparation method and application 北京勤邦生物技术有限公司 2019-01-11 CN claimed
CN-107119334-A A kind of apocynum fibre degumming method of comprehensive utilization 梁国柱 2017-09-01 CN claimed
EP-3658557-B1 TYK2 INHIBITORS AND USES THEREOF TAKEDA PHARMACEUTICALS CO (JP) 2024-06-05 EP disclosed
US-20240166646-A1 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES NEWAVE PHARMACEUTICAL INC. 2024-05-23 US disclosed
EP-4063358-B1 HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS INC (US) 2024-05-22 EP disclosed
CN-114316102-B Alkoxy magnesium carrier, polyethylene catalyst and preparation method thereof 北京吉海川科技发展有限公司 2023-12-22 CN disclosed
US-11780834-B2 Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use GENENTECH, INC. (US) 2023-10-10 US disclosed
US-11713299-B2 Histone methyltransferase inhibitors GLOBAL BLOOD THERAPEUTICS, INC. (US) 2023-08-01 US disclosed
WO-2002085920-A2 ALKANE AND ALKANE GROUP DEHYDROGENATION WITH ORGANOMETALLIC CATALYSTS ORALBEKOV, BAKYTZHAN (RU) 2002-10-31 WO disclosed
US-5175183-A Antiinflammatory agents, respiratory system disorders ABBOTT LABORATORIES (US) 1992-12-29 US disclosed
US-5068251-A Nonsteroidal antiinflammatory agents, hydroxyurea derivatives ABBOTT LABORATORIES (US) 1991-11-26 US disclosed
US-4992464-A Bronchodilator, antiinflammatory, antiarthritic, antiallergenic agents ABBOTT LABORATORIES (US) 1991-02-12 US disclosed
WO-1990008545-A1 LIPOXYGENASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1990-08-09 WO disclosed
EP-0374602-A1 Lipoxygenase inhibiting compounds ABBOTT LABORATORIES (US) 1990-06-27 EP disclosed
EP-0136893-B1 Benzo[a]phenothiazines and hydro-derivatives and pharmaceutical compositions containing them MERCK FROSST CANADA INC. (CA) 1989-08-16 EP disclosed